83 related articles for article (PubMed ID: 1765954)
1. Results of a prenatal screening program for the human immunodeficiency virus in a cross-sectional population.
Horowitz GM; Scott RT; Hankins GD
J Reprod Med; 1991 Nov; 36(11):773-8. PubMed ID: 1765954
[TBL] [Abstract][Full Text] [Related]
2. Rapid HIV versus enzyme-linked immunosorbent assay screening in a low-risk Mexican American population presenting in labor: a cost-effectiveness analysis.
Doyle NM; Levison JE; Gardner MO
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1280-5. PubMed ID: 16157152
[TBL] [Abstract][Full Text] [Related]
3. Routine antepartum human immunodeficiency virus infection screening in an inner-city population.
Lindsay MK; Peterson HB; Feng TI; Slade BA; Willis S; Klein L
Obstet Gynecol; 1989 Sep; 74(3 Pt 1):289-94. PubMed ID: 2761902
[TBL] [Abstract][Full Text] [Related]
4. Measurement of the false positive rate in a screening program for human immunodeficiency virus infections.
Burke DS; Brundage JF; Redfield RR; Damato JJ; Schable CA; Putman P; Visintine R; Kim HI
N Engl J Med; 1988 Oct; 319(15):961-4. PubMed ID: 3419477
[TBL] [Abstract][Full Text] [Related]
5. Unlinked anonymous screening of antenatal patients for antibody to human immunodeficiency virus type 1 (HIV-1).
Chew CB; Downie JC; Cunningham AL
Med J Aust; 1994 Jun; 160(11):693-6. PubMed ID: 8202003
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of an expanded two-ELISA approach for confirmation of reactive serum samples in an HIV-screening programme for pregnant women.
Van Doornum GJ; Buimer M; Gobbers E; Bindels PJ; Coutinho RA
J Med Virol; 1998 Apr; 54(4):285-90. PubMed ID: 9557294
[TBL] [Abstract][Full Text] [Related]
7. Routine human immunodeficiency virus infection screening of women requesting induced first-trimester abortion in an inner-city population.
Lindsay MK; Peterson HB; Taylor EB; Blunt M; Willis S; Klein L
Obstet Gynecol; 1990 Sep; 76(3 Pt 1):347-50. PubMed ID: 2381611
[TBL] [Abstract][Full Text] [Related]
8. Routine human immunodeficiency virus infection screening in unregistered and registered inner-city parturients.
Lindsay MK; Feng TI; Peterson HB; Slade BA; Willis S; Klein L
Obstet Gynecol; 1991 Apr; 77(4):599-603. PubMed ID: 2002985
[TBL] [Abstract][Full Text] [Related]
9. Followup study of possible HIV seropositivity among abusers of parenteral drugs in 1971-72.
Lange WR; Ball JC; Adler WH; Brown E; Pyle R; Hoffman W; Dax EM
Public Health Rep; 1991; 106(4):451-5. PubMed ID: 1908596
[TBL] [Abstract][Full Text] [Related]
10. HIV seroconversion without infection after receipt of adenovirus-vectored HIV type 1 vaccine.
Quirk EK; Mogg R; Brown DD; Lally MA; Mehrotra DV; DiNubile MJ; Robertson MN
Clin Infect Dis; 2008 Dec; 47(12):1593-9. PubMed ID: 18990058
[TBL] [Abstract][Full Text] [Related]
11. [Could saliva be used to detect HIV seroconversion?].
Sangaré KA; Koffi AR; Coulibaly IM; Doulourou C
Sante; 1997; 7(5):303-7. PubMed ID: 9480036
[TBL] [Abstract][Full Text] [Related]
12. High false-positive rate of human immunodeficiency virus rapid serum screening in a predominantly hispanic prenatal population.
Zacharias NM; Athanassaki ID; Sangi-Haghpeykar H; Gardner MO
J Perinatol; 2004 Dec; 24(12):743-7. PubMed ID: 15318249
[TBL] [Abstract][Full Text] [Related]
13. Immunofluorescence, enzyme-linked immunosorbent assay, particle agglutination and western blot for the detection of antibody to human immunodeficiency virus type 1.
Auwanit W; Ayuthaya PI; Balachandra K; Jayavasu C; Phanthumachinda B; Ikuta K; Yamanishi K; Kanai K
Southeast Asian J Trop Med Public Health; 1990 Mar; 21(1):53-9. PubMed ID: 2205928
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of two commercial human immunodeficiency virus serological tests in cases with indeterminate Western blot results.
Huang LJ; Liu CY; Chu SC; Wong WW; Lin YC; Liu WT; Chan YJ
J Microbiol Immunol Infect; 2006 Jun; 39(3):219-24. PubMed ID: 16783452
[TBL] [Abstract][Full Text] [Related]
15. Risk factor analysis and serological diagnosis of HIV-1/HIV-2 infection in a Brazilian blood donor population: validation of the World Health Organization strategy for HIV testing.
Carvalho MB; Hamerschlak N; Vaz RS; Ferreira OC
AIDS; 1996 Sep; 10(10):1135-40. PubMed ID: 8874631
[TBL] [Abstract][Full Text] [Related]
16. Voluntary newborn HIV-1 antibody testing: a successful model program for the identification of HIV-1-seropositive infants.
Abrams EJ; Bateman DA
Bull N Y Acad Med; 1995; 72(2):443-53. PubMed ID: 10101381
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus infection in hemodialysis patients. Baltimore-Boston Collaborative Study Group.
Arch Intern Med; 1988 Mar; 148(3):617-9. PubMed ID: 3341863
[TBL] [Abstract][Full Text] [Related]
18. HIV infection and zidovudine use in childbearing women.
Sia J; Paul S; Martin RM; Cross H
Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
[TBL] [Abstract][Full Text] [Related]
19. Contingent screening for Down syndrome is an efficient alternative to non-disclosure sequential screening.
Wright D; Bradbury I; Benn P; Cuckle H; Ritchie K
Prenat Diagn; 2004 Oct; 24(10):762-6. PubMed ID: 15503281
[TBL] [Abstract][Full Text] [Related]
20. Detection of anti-HIV-1 IgG antibodies in whole saliva by GACELISA and Western blot assays.
Matee MI; Lyamuya EF; Simon E; Mbena EC; Kagoma C; Samaranayake LP; Scheutz F
East Afr Med J; 1996 May; 73(5):292-4. PubMed ID: 8756029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
